Illinois hospitals’ tax exemptions at risk in court case

The Illinois Supreme Court will decide on a state law in 2012 allowing nonprofit hospitals to more easily receive property tax exemptions, potentially threatening millions of dollars in tax benefits for healthcare facilities in Illinois.

According to the State Journal-Register, the court case rests on whether the 2012 statute makes a clear requirement that the hospitals’ charitable services at least equal the value of what they would otherwise pay in taxes. The plaintiff, Constance Oswald, has argued the law replaces the standard charitable requirement and therefore violates the Illinois Constitution and previous court rulings.

Oswald’s argument was already rejected at the county level and again on appeal, but nonprofit hospitals in Illinois have dealt with other court cases challenging their tax-exempt status. In 2010, the state Supreme Court did rule Provena Covenant Medical Center in Urbana, Illinois, wasn’t providing enough charity care to avoid paying property taxes.

If hospitals lose in this case, their lobbying groups have warned of dire consequences.

“We have a lot of hospitals that are operating either in the red or very close to it,” said attorney Steven Pflaum, who is representing the Illinois Health and Hospital Association. “So now having to shoulder millions of dollars in property tax liability would be a significant problem for many of our hospitals.”

Whether nonprofit hospitals provide enough charitable contributions to justify their tax exemptions has been repeatedly questioned in recent years. Studies have shown those facilities haven’t greatly increased community benefit spending—and may have actually cut back on charity care—even as the Affordable Care Act led to big increases in revenue.

Read more at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.